<DOC>
	<DOCNO>NCT00516139</DOCNO>
	<brief_summary>This study conduct determine safety tolerability lamotrigine ( LTG ) elderly patient epilepsy . This study carry use extended-release formulation lamotrigine ( LTG-XR ) allow once-a-day dosing .</brief_summary>
	<brief_title>Lamotrigine Extended-Release In Elderly Patients With Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>Inclusion criterion : Confident diagnosis epilepsy Currently treat one two antiepileptic medication Able complete seizure diary Exclusion criterion : History hypersensitivity lamotrigine Progressive disease would interfere study objective</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Epilepsy elderly seizure</keyword>
</DOC>